Startups
Edit
Gene Therapy Program | University of Pennsylvania
https://gtp.med.upenn.edu/Last activity: 27.04.2026
Active
Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases.
Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy.
After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published more than 550 papers and is named on more than 110 patents.
Today, the goals of the Gene Therapy Program are to develop and commercialize transformative, genetic-based therapeutics. These goals are driven by the unmet needs of patients with inherited genetic diseases.
The Gene Therapy Program currently employs more than 300 full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.
Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy.
After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published more than 550 papers and is named on more than 110 patents.
Today, the goals of the Gene Therapy Program are to develop and commercialize transformative, genetic-based therapeutics. These goals are driven by the unmet needs of patients with inherited genetic diseases.
The Gene Therapy Program currently employs more than 300 full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.
Overview
Location
United States, Pennsylvania, Philadelphia
Employees
201-500
Founded date
1993
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 17, 2023 | BlueWhale Bio: University Of Pennsylvania Gene Therapy Spinoff Company Raises $18 Million | BlueWhale Bio – a new company that spun out of the University of Pennsylvania to overcome key bottlenecks in cell and gene therapy manufacturing – recently announced that it has raised $18 million in seed financing. This funding round was l... |
| Sep 10, 2021 | Penn gene editing spinout iECURE just raised a $50M Series A | The life sciences have made a strong showing in the Greater Philadelphia region this year, as local companies raked in a record $777 million in venture capital in the first half of 2021 alone. Add it to the tally: A University of Pennsylvan... |
| Mayo Clinic announces $100 million gift for proton beam therapy program | The Mayo Clinic announced Thursday that a longtime patient and philanthropist has donated $100 million to help establish a cancer-fighting proton beam therapy program. The money will help fund Mayo’s proton beam therapy program, which will ... |
Reviews 0
FAQ about Gene Therapy Program | University of Pennsylvania
When was Gene Therapy Program | University of Pennsylvania founded?
Gene Therapy Program | University of Pennsylvania was founded in 1993.
What has the press written about Gene Therapy Program | University of Pennsylvania?
Parsers VC has collected 4 articles mentioning Gene Therapy Program | University of Pennsylvania, among them “BlueWhale Bio: University Of Pennsylvania Gene Therapy Spinoff Company Raises $18 Million” (Sep 17, 2023) and “Penn gene editing spinout iECURE just raised a $50M Series A” (Sep 10, 2021).
Is Gene Therapy Program | University of Pennsylvania still active?
Yes, Gene Therapy Program | University of Pennsylvania is active; its latest activity on Parsers VC dates from Apr 27, 2026.